Minimal clinically important difference on the Beck Depression Inventory-II according to the patient's perspective

Psychological Medicine

Volumn 45, Issue 15, 2015, Pages 3269-3279

  Button, K S ^a   Kounali, D ^a   Thomas, L ^a   Wiles, N J ^a   Peters, T J ^b   Welton, N J ^a   Ades, A E ^a   Lewis, G ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

2nd edition (BDI II); Beck Depression Inventory; depression; minimal clinically important difference; outcome assessment; primary care

Indexed keywords

ADULT; DEPRESSION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEVERITY OF ILLNESS INDEX; STANDARDS;

ADULT; DEPRESSION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX;

EID: 84944278446     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291715001270     Document Type: Article

References (26)

1. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). American Psychiatric Association: Washington, DC.
2. Beck A, Steer RA, Brown GK (1996). Beck Depression Inventory-Second Edition: Manual. The Psychological Corporation: San Antonio, TX.
3. Chalder M, Wiles NJ, Campbell J, Hollinghurst SP, Haase AM, Taylor AH, Fox KR, Costelloe C, Searle A, Baxter H, Winder R, Wright C, Turner KM, Calnan M, Lawlor DA, Peters TJ, Sharp DJ, Montgomery AA, Lewis G (2012). Facilitated physical activity as a treatment for depressed adults: randomised controlled trial. British Medical Journal 344, e2758.
4. Claeskens G, Hjort NL (2008). Model Selection and Model Averaging. Cambridge University Press: Cambridge.
5. D'Agostino RB, Weintraub M (1995). Meta-analysis: a method for synthesizing research. Clinical Pharmacology and Therapeutics 58, 605-616.
6. Dunlop BW, Li T, Kornstein SG, Friedman ES, Rothschild AJ, Pedersen R, Ninan P, Keller M, Trivedi MH (2011). Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder. Journal of Psychiatric Research 45, 96-103.
7. Fitzpatrick R (1998). Evaluating Patient-based Outcome Measures for Use in Clinical Trials. Core Research, on behalf of the NCCHTA: Alton.
8. Forkmann T, Scherer A, Boecker M, Pawelzik M, Jostes R, Gauggel S (2011). The Clinical Global Impression Scale and the influence of patient or staff perspective on outcome. BMC Psychiatry 11, 83.
9. Furukawa TA, Akechi T, Azuma H, Okuyama T, Higuchi T (2007). Evidence-based guidelines for interpretation of the Hamilton Rating Scale for Depression. Journal of Clinical Psychopharmacology 27, 531-534.
10. Hardin JW & Hilbe JM (2007). Generalized Linear Models and Extensions. Stata Press: College Station, TX.
11. Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. British Medical Journal 327, 557-560.
12. Hiroe T, Kojima M, Yamamoto I, Nojima S, Kinoshita Y, Hashimoto N, Watanabe N, Maeda T, Furukawa TA (2005). Gradations of clinical severity and sensitivity to change assessed with the Beck Depression Inventory-II in Japanese patients with depression. Psychiatry Research 135, 229-235.
13. Jacobson NS, Truax P (1991). Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology 59, 12-19.
14. Jaeschke R, Singer J, Guyatt GH (1989). Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials 10, 407-415.
15. Kelly MJ, Dunstan FD, Lloyd K, Fone DL (2008). Evaluating cutpoints for the MHI-5 and MCS using the GHQ-12: a comparison of five different methods. BMC Psychiatry 8, 10.
16. Lewis G, Mulligan J, Wiles N, Cowen P, Craddock N, Ikeda M, Grozeva D, Mason V, Nutt D, Sharp D, Tallon D, Thomas L, O'Donovan MC, Peters TJ (2011). Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial. British Journal of Psychiatry 198, 464-471.
17. Lunn DJ, Thomas A, Best N, Spiegelhalter D (2000). WinBUGS-A Bayesian modelling framework: concepts, structure, and extensibility. Statistics and Computing 10, 325-337.
18. McCullagh P, Nelder JA (1989). Generalized Linear Models. Chapman and Hall: London, New York.
19. McGlothlin AE, Lewis RJ (2014). Minimal clinically important difference: defining what really matters to patients. Journal of the American Medical Association 312, 1342-1343.
20. McMillan D, Gilbody S, Richards D (2010). Defining successful treatment outcome in depression using the PHQ-9: a comparison of methods. Journal of Affective Disorders 127, 122-129.
21. NCCMH (2004). Depression: Management of Depression in Primary and Secondary Care. British Psychological Society and Royal College of Psychiatrists: Leicester and London [full guideline].
22. Pepe MS (2003). The Statistical Evaluation of Medical Tests for Classification and Prediction. Oxford University Press: Oxford.
23. Perkins NJ, Schisterman EF (2006). The inconsistency of 'optimal' cutpoints obtained using two criteria based on the receiver operating characteristic curve. American Journal of Epidemiology 163, 670-675.
24. Vanheule S, Desmet M, Groenvynck H, Rosseel Y, Fontaine J (2008). The factor structure of the Beck Depression Inventory-II: an evaluation. Assessment 15, 177-187.
25. Walters SJ, Brazier JE (2003). What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health and Quality Life Outcomes 1, 4.
26. Wiles N, Thomas L, Abel A, Ridgway N, Turner N, Campbell J, Garland A, Hollinghurst S, Jerrom B, Kessler D, Kuyken W, Morrison J, Turner K, Williams C, Peters T, Lewis G (2013). Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet 381, 375-384.